Topical permeation enhancers efficiently deliver polymer micro and nanoparticles to epidermal Langerhans' cells

Journal of Drug Delivery Science and Technology

Volumn 14, Issue 4, 2004, Pages 265-273

  Gu, H ^a   Roy, K ^a  

^a The University of Texas at Austin   (United States)

Author keywords

Langerhans' cells; Nanoparticles; Permeation enhancers; Skin; Vaccine

Indexed keywords

ANTIGEN; DIETHYLENE GLYCOL MONOETHYL ETHER; GELUCIRE; LABRASOL; NANOPARTICLE; PENETRATION ENHANCING AGENT; POLYGLACTIN; POLYMER; SORBITAN LAURATE; VACCINE;

ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; BIODEGRADABILITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SAFETY; EPIDERMIS CELL; FEMALE; FLUORESCENCE MICROSCOPY; FROZEN SECTION; GENE TARGETING; IMMUNITY; IMMUNOHISTOCHEMISTRY; LANGERHANS CELL; MOUSE; NONHUMAN; PARTICLE SIZE; PATIENT COMPLIANCE;

EID: 4344561038     PISSN: 11571489     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1773-2247(04)50047-3     Document Type: Article

References (30)

1. Immunisation W.H.O.E.P.O. - Reducing the risk of unsafe injections in immunisation programs: the role of injection equipment. - 1996.
2. TUTING T. - The immunology of cutaneous DNA immunization. - Curr. Opin. Mol. Ther., 1 (2), 216-225, 1999.
3. FALO L.D. Jr. - Targeting the skin for genetic immunization. - Proc. Assoc. Am. Physicians, 111 (3), 211-219, 1999.
4. ROY M.J., WU M.S., BARR L.J., FULLER J.T., TUSSEY L.G., SPELLER S., CULP J., BURKHOLDER J.K., SWAIN W.F., DIXON R.M. et al. - Induction of antigen-specific CD8+ T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine. - Vaccine, 19 (7-8), 764-778, 2000.
5. GLENN G.M., SCHARTON-KERSTEN T., VASSELL R., MALLETT C.P., HALE T.L., ALVING C.R. - Transcutaneous immunization with cholera toxin protects mice against lethal mucosal toxin challenge. - J. Immunol., 161 (7), 3211-3214, 1998.
6. GLENN G.M., SCHARTON-KERSTEN T., VASSELL R., MATYAS G.R., ALVING C.R. - Transcutaneous immunization with bacterial ADP-ribosylating exotoxins as antigens and adjuvants. - Infect. Immun., 67 (3), 1100-1106, 1999.
7. GLENN G.M., TAYLOR D.N., LI X., FRANKEL S., MONTEMARANO A., ALVING C.R. - Transcutaneous immunization: a human vaccine delivery strategy using a patch. - Nat. Med., 6 (12), 1403-1406, 2000.
8. GOCKEL C.M., BAO S., BEAGLEY K.W. - Transcutaneous immunization induces mucosal and systemic immunity: a potent method for targeting immunity to the female reproductive tract. - Mol. Immunol., 37 (9), 537-544, 2000.
9. PERTMER T.M., ROBERTS T.R., HAYNES J.R. - Influenza virus nucleoprotein-specific immunoglobulin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery. - J. Virol., 70 (9), 6119-6125, 1996.
10. CARDOSO A.I., SIXT N., VALLIER A., FAYOLLE J., BUCKLAND R., WILD T.F. - Measles virus DNA vaccination: antibody isotype is determined by the method of immunization and by the nature of both the antigen and the coimmunized antigen. - J. Virol., 72 (3), 2516-2518, 1998.
11. BARRY B.W. - Novel mechanisms and devices to enable successful transdermal drug delivery. - Eur. J. Pharm. Sci., 14 (2), 101-114, 2001.
12. HAMMOND S.A., WALWENDER D., ALVING C.R., GLENN G.M. -Transcutaneous immunization: T cell responses and boosting of existing immunity. - Vaccine, 19 (17-19), 2701-2707, 2001.
13. SCHARTON-KERSTEN T., YU J., VASSELL R., O'HAGAN D., ALVING C.R., GLENN G.M. - Transcutaneous immunization with bacterial ADP-ribosylating exotoxins, subunits, and unrelated adjuvants. - Infect. Immun., 68 (9), 5306-5313, 2000.
14. JONES D.H., CORRIS S., MCDONALD S., CLEGG J.C., FARRAR G.H. - Poly(DL-lactide-co-glycolide)-encapsulated plasmid DNA elicits systemic and mucosal antibody responses to encoded protein after oral administration. - Vaccine, 15 (8), 814-817, 1997.
15. JONES D.H., PARTIDOS C.D., STEWARD M.W., FARRAR G.H. - Oral delivery of poly(lactide-co-glycolide) encapsulated vaccines. - Behring Inst. Mitt., (98), 220-228, 1997.
16. CUI Z., MUMPER R.J. - Chitosan-based nanoparticles for topical genetic immunization. - J. Control. Release, 75 (3), 409-419, 2001.
17. SINGH M., BRIONES M., OTT G., O'HAGAN D. - Cationic microparticles: A potent delivery system for DNA vaccines. - Proc. Natl. Acad. Sci. USA, 97 (2), 811-816, 2000.
18. VAJDY M., O'HAGAN D.T. - Microparticles for intranasal immunization. - Adv. Drug Deliv. Rev., 51 (1-3), 127-141, 2001.
19. O'HAGAN D.T., MACKICHAN M.L., SINGH M. - Recent developments in adjuvants for vaccines against infectious diseases. - Biomol. Eng., 18 (3), 69-85, 2001.
20. ROY K., WU Y.C., CHAMBERS R, HEDLEY M.L., BARMAN S.P. - Gene delivery with microspheresand crosslinked polymer networks for systemic protein expression. - San Diego, CA, June 2001.
21. McKEEVER U., BARMAN S., HAO T., CHAMBERS R, SONG S., LUNSFORD L., HSU Y.Y., ROY K., HEDLEY M.L. - Protective immune responses elicited in mice by immunization with formulations of poly(lactide-co-glycolide) microparticles. - Vaccine, 20 (11-12), 1524-1531, 2002.
22. BIRNBAUM D.T., BRANNON-PEPPAS L. - Molecular weight distribution changes during degradation and release of PLGA nanoparticles containing epirubicin HCl. - J. Biomater. Sci. Polym. Ed., 14 (1), 87-102, 2003.
23. ANGELI V., FAVEEUW C., ROYE O., FONTAINE J., TEISSIER E., CAPRON A., WOLOWCZUK I., CAPRON M., TROTTEIN F. - Role of the parasite-derived prostaglandin D2 in the inhibition of epidermal Langerhans cell migration during schistosomiasis infection. - J. Exp. Med., 193 (10), 1135-1147, 2001.
24. CUMBERBATCH M., DEARMAN R.J., KIMBER I. - Interleukin 1 beta and the stimulation of Langerhans cell migration: comparisons with tumour necrosis factor alpha. - Arch. Dermatol. Res., 289 (5), 277-284, 1997.
25. LOPEZ-CASTELLANO A., CORTELL-IVARS C., LOPEZ-CARBALLO G., HERRAEZ-DOMINGUEZ M. - The influence of Span 20 on stratum corneum lipids in langmuir monolayers: comparison with Azone. - Int. J. Pharm., 203 (1-2), 245-253, 2000.
26. LARRUCEA E., ARELLANO A., SANTOYO S., YGARTUA P. - Combined effect of oleic acid and propylene glycol on the percutaneous penetration of tenoxicam and its retention in the skin. - Eur. J. Pharm. Biopharm., 52 (2), 113-119, 2001.
27. MURA R, FAUCCI M.T., BRAMANTI G., CORTI P. - Evaluation of transcutol as a clonazepam transdermal permeation enhancer from hydrophilic gel formulations. - Eur. J. Pharm. Sci., 9 (4), 365-372, 2000.
28. OH S.Y., JEONG S.Y., PARK T.G., LEE J.H. - Enhanced transdermal delivery of AZT (zidovudine) using iontophoresis and penetration enhancer. - J. Control. Release, 51 (2-3), 161-168, 1998.
29. CORNWELL P.A., BARRY B.W., STODDART C.P., BOUWSTRA J.A. - Wide-angle X-ray diffraction of human stratum corneum: effects of hydration and terpene enhancer treatment. - J. Pharm. Pharmacol., 46 (12), 938-950, 1994.
30. LAPPIN M.B., KIMBER I., NORVAL M. - The role of dendritic cells in cutaneous immunity. - Arch. Dermatol. Res., 288 (3), 109-121, 1996.